27.32
price up icon1.07%   0.29
after-market Handel nachbörslich: 27.32
loading
Schlusskurs vom Vortag:
$27.03
Offen:
$26.8
24-Stunden-Volumen:
1.07M
Relative Volume:
1.10
Marktkapitalisierung:
$2.18B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-36.43
EPS:
-0.75
Netto-Cashflow:
$40.13M
1W Leistung:
+1.64%
1M Leistung:
+2.67%
6M Leistung:
-31.01%
1J Leistung:
+28.08%
1-Tages-Spanne:
Value
$26.59
$27.74
1-Wochen-Bereich:
Value
$26.01
$27.74
52-Wochen-Spanne:
Value
$19.73
$47.32

Veracyte Inc Stock (VCYT) Company Profile

Name
Firmenname
Veracyte Inc
Name
Telefon
(650) 243-6300
Name
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
824
Name
Twitter
@veracyte
Name
Nächster Verdiensttermin
2025-02-24
Name
Neueste SEC-Einreichungen
Name
VCYT's Discussions on Twitter

Vergleichen Sie VCYT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
VCYT
Veracyte Inc
27.32 2.18B 399.58M -54.04M 40.13M -0.75
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
421.47 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
201.10 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
542.65 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.45 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
162.61 27.64B 15.50B 1.33B 2.16B 7.34

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-20 Eingeleitet Craig Hallum Buy
2024-12-05 Herabstufung Goldman Buy → Neutral
2024-11-15 Eingeleitet Wolfe Research Outperform
2024-10-16 Eingeleitet UBS Buy
2024-10-10 Eingeleitet Guggenheim Buy
2024-02-23 Bestätigt Needham Buy
2023-01-18 Herabstufung Raymond James Outperform → Mkt Perform
2023-01-05 Eingeleitet Scotiabank Sector Outperform
2022-01-07 Eingeleitet Stephens Overweight
2021-11-18 Fortgesetzt Goldman Buy
2021-06-15 Eingeleitet Raymond James Outperform
2021-02-18 Fortgesetzt Needham Buy
2021-01-28 Eingeleitet Truist Buy
2020-11-10 Eingeleitet KeyBanc Capital Markets Sector Weight
2020-09-09 Eingeleitet Morgan Stanley Underweight
2019-07-31 Eingeleitet Lake Street Buy
2019-07-02 Eingeleitet Needham Buy
2018-11-29 Herabstufung Janney Buy → Neutral
2018-10-31 Hochstufung Janney Neutral → Buy
2017-11-07 Herabstufung Janney Buy → Neutral
2017-11-07 Herabstufung Piper Jaffray Overweight → Neutral
2017-08-31 Fortgesetzt BTIG Research Buy
2016-11-14 Fortgesetzt Leerink Partners Outperform
2015-12-18 Eingeleitet Cantor Fitzgerald Buy
2015-06-11 Bestätigt Leerink Partners Outperform
2013-11-26 Eingeleitet William Blair Outperform
Alle ansehen

Veracyte Inc Aktie (VCYT) Neueste Nachrichten

pulisher
Jun 18, 2025

Veracyte shareholders approve 2.5 million share increase to equity plan - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Veracyte shareholders approve 2.5 million share increase to equity plan By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 17, 2025

Insider Sell: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus

Jun 17, 2025
pulisher
Jun 15, 2025

Veracyte, Inc.'s (NASDAQ:VCYT) Shares Lagging The Industry But So Is The Business - simplywall.st

Jun 15, 2025
pulisher
Jun 09, 2025

Veracyte (VCYT) Fell Despite Reporting Revenue Growth and Improved Profitability - Insider Monkey

Jun 09, 2025
pulisher
Jun 07, 2025

Cathie Wood's Ark Invest Loads Up On Veracyte, Offloads 3D Systems - Benzinga

Jun 07, 2025
pulisher
Jun 06, 2025

Insider Selling: John Leite Sells Shares of Veracyte Inc (VCYT) - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Veracyte chief commercial officer sells shares for $76,409 By Investing.com - Investing.com Canada

Jun 06, 2025
pulisher
Jun 06, 2025

Veracyte chief commercial officer sells shares for $76,409 - Investing.com Australia

Jun 06, 2025
pulisher
Jun 06, 2025

Cathie Wood’s ARK buys Veracyte, sells AvidXchange and 3D Systems stock By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Cathie Wood’s ARK buys Veracyte, sells AvidXchange and 3D Systems stock - Investing.com Nigeria

Jun 06, 2025
pulisher
Jun 06, 2025

Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Top Companies in the NASDAQ Veracyte and Others by Kalkine - Kalkine Media

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Cuts Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Veracyte at Jefferies Global Healthcare Conference: Strategic Growth and Innovation - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 04, 2025

Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant By Investing.com - Investing.com Nigeria

Jun 04, 2025
pulisher
Jun 04, 2025

Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Veracyte (VCYT) Shares Pulled Back Despite Beating Expectations - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Veracyte at William Blair Growth Stock Conference: Strategic Insights Unveiled - Investing.com Canada

Jun 04, 2025
pulisher
Jun 01, 2025

Veracyte (NASDAQ:VCYT) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Veracyte, Inc. (VCYT) Presents Breakthrough Genomic Data to Predict Cancer Therapy Response at ASCO - MSN

May 31, 2025
pulisher
May 29, 2025

Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research - BioSpace

May 29, 2025
pulisher
May 29, 2025

Veracyte, Inc. (NASDAQ:VCYT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

May 29, 2025
pulisher
May 28, 2025

Veracyte (VCYT) Showcases Findings at ASCO Annual Meeting | VCYT Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Veracyte to present multiple abstracts at ASCO - TipRanks

May 28, 2025
pulisher
May 28, 2025

Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research | VCYT Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Veracyte Inc (VCYT) Shares Gap Down to $26.74 on May 28 - GuruFocus

May 28, 2025
pulisher
May 26, 2025

Veracyte: Upgrading To Neutral (NASDAQ:VCYT) - Seeking Alpha

May 26, 2025
pulisher
May 23, 2025

Captrust Financial Advisors Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

May 23, 2025
pulisher
May 21, 2025

Scotiabank maintains Veracyte stock with $44 target - Investing.com

May 21, 2025
pulisher
May 21, 2025

Scotiabank maintains Veracyte stock with $44 target By Investing.com - Investing.com India

May 21, 2025
pulisher
May 21, 2025

Deutsche Bank AG Has $3.22 Million Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

May 21, 2025
pulisher
May 20, 2025

Veracyte to Participate in Upcoming Investor Conferences - 01net

May 20, 2025
pulisher
May 20, 2025

Veracyte to Participate in Upcoming Investor Conferences | VCYT Stock News - GuruFocus

May 20, 2025
pulisher
May 19, 2025

Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally? - Zacks Investment Research

May 19, 2025
pulisher
May 18, 2025

BNP Paribas Financial Markets Sells 55,684 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World

May 18, 2025
pulisher
May 17, 2025

William Blair Estimates Veracyte’s Q2 Earnings (NASDAQ:VCYT) - Defense World

May 17, 2025
pulisher
May 13, 2025

Stifel Financial Corp Sells 2,211 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World

May 13, 2025
pulisher
May 11, 2025

Veracyte projects strong Decipher and Afirma growth, targets 22.5% adjusted EBITDA margin for 2025 - MSN

May 11, 2025

Finanzdaten der Veracyte Inc-Aktie (VCYT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Veracyte Inc-Aktie (VCYT) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Bhanji Muna
Director
Jun 13 '25
Sale
26.67
4,589
122,367
29,989
diagnostics_research DGX
$179.33
price down icon 0.17%
diagnostics_research WAT
$357.04
price up icon 2.29%
diagnostics_research LH
$264.26
price up icon 0.67%
$160.72
price down icon 4.87%
diagnostics_research MTD
$1,205.29
price up icon 2.60%
diagnostics_research IQV
$162.61
price up icon 3.19%
Kapitalisierung:     |  Volumen (24h):